Serial Number
79081227
Owner
ThromboGenics NVAttorney
Lisa Greenwald-SwireFiling Date
Jan 19, 2010
THROMBOGENICS Trademark
Serial Number: 79081227
Trademark Classes
Class 1 - Chemicals
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Class 5 - Pharmaceuticals
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Class 42 - Computer & Scientific
Scientific and technological services; industrial analysis and research services
Class 44 - Medical Services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Owner Contact Info
Legal Representation
Trademark Details
Filing Date
January 19, 2010
Registration Date
Not Registered
Goods & Services
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides; biopharmaceutical preparations; diagnostic medical reagents, chemicals and biological materials both as spatially defined arrays and solutions or reagents for medical laboratory use in diagnosting, monitoring, and predicting diseases and for measuring or predicting response to therapy of cardiac and vascular diseases; pharmaceutical preparations for use in the treatment of hypertension, strokes, cardiac diseases and vascular diseases
Chemical preparations and substances for use in the manufacture of pharmaceutical products
Medical services; veterinary services; medical, veterinary and pharmaceutical advisory and consultancy services; medical services, namely, cardiac and vascular therapeutic, prognostic and diagnostic testing services
Scientific and technological services and research and design relating thereto; industrial analysis and research services; pharmaceutical and biopharmaceutical research and development; (bio)pharmaceutical product evaluation; research into treatment of cardio vascular disease, cardiac disease, and vascular disease; development of new treatments for pathologies in which vascular biology plays a critical role in the field of biopharmaceuticals